Barely Significant
← all excerpts

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab.

Int J Infect Dis · 2020 · PMC7406519 · PMID 32768693

Europe PMCDOI
1
hedged sentence
0.1100
closest p · 2.2× alpha
0.1100
boldest claim

The sentences

did not reach statistical significancep = 0.11not close (p > 0.1)
Unadjusted analysis indicated a survival advantage with anakinra compared to tocilizumab-treated patients ( Figure 2 ), but after adjustment for multiple baseline imbalances, this difference did not reach statistical significance (PS-adjusted HR = 0.46, 95%CI = 0.18–1.20, p = 0.11).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.